Amedica closed its most recent underwritten public offering of $12.7 million.
Here are four points:
1. In total, Amedica issued 3.6 million shares of common stock, 7,392 shares of preferred stock convertible into 7.4 million shares of common stock as well as warrants to purchase 11 million shares of common stock.
2. The underwriters have exercised their option to purchase 1.6 million additional shares of common stock and warrants to purchase up to an additional 1.6 million shares of common stock.
3. The company will use the gross proceeds of $12.7 million (before deducting underwriting discounts and commissions and Amedica's estimated offering expenses) to support its growth.
4. Ladenburg Thalmann, a subsidiary of Ladenburg Thalmann Financial Services, and Maxim Group acted as joint book-running managers in connection with the offering.